Skip To Main Content
Payton Clark on Muck Rack

Payton Clark

As seen in: Nature, Wiley Online Library
Back to Payton Clark’s profile

Articles by Payton Clark

Tumor-informed molecular residual disease in resected mucosal and cutaneous squamous cell carcinomas of the head and neck

|
By Payton Clark, Neil Woody, Mark D. Orland, Shauna R. Campbell, Jamie Ku, Natalie Silver, Danielle Bottalico, Brandon Prendes, Eric Lamarre, Joseph Scharpf, Tamara Sussman, Jessica Geiger, Kyunghee Burkitt, Mahmoud Summers, Tyler J. Alban, Claudia Diaz, Christopher Griffith, Josephine K. Dermawan, Daniel J. McGrail, Timothy Chan, Emrullah Yilmaz, Shlomo Koyfman, Jacob Miller, Natalya Karasik, Alfred Kotarja, Shikha Parsai, Christine Lee-Poturalski
| Nature Verified
Abstract Patients with resected mucosal (HNSCC) or cutaneous (cSCC) squamous carcinomas of the head and neck undergo adjuvant therapy based on clinicopathologic prognosticators. Most patients are overtreated or undertreated, with substantial morbidity from locoregional recurrences and locoregional therapies. It is unknown whether postoperative ctDNA molecular residual disease (MRD) testing could improve patient selection.
Open in Who Shared Issue with article?

Examining Recruitment and Retention Strategies for Underserved Populations in Thyroid Cancer Clinical Trials: A Cross-Sectional Analysis

|
By Ryan Sherry, Ethan Wood, Payton Clark
| Wiley Online Library Verified
1 Introduction Thyroid cancer represents a growing public health concern in the United States as incidence and mortality rates have markedly increased over the last several decades [1]. According to the National Cancer Institute (NCI) of the National Institutes of Health (NIH), there are an estimated 44,020 new cases in 2024, with a projected 2170 deaths [2].
Open in Who Shared Issue with article?
Show More